All News

New findings show that 43% of patients with certain blood cancers produced COVID-19 antibodies after receiving a third full dose of the mRNA vaccine.

A male breast cancer survivor discusses the fear and fabrications created in his head and how he deals with them.

On this episode of the “Cancer Horizons” podcast, a colorectal cancer survivor explains how she was the last patient to receive a colonoscopy leading to her stage 3 diagnosis as her doctor’s office shut down because of COVID-19 in March 2020.

Additional advancements in how radical prostatectomy is performed are needed to improve other urinary outcomes such as good urinary function and social incontinence.

Communication, self-advocacy and having someone in your corner are all critical tools to bring to a cancer care visit, says an expert from MedStar Georgetown University Hospital.

CURE® takes a look back at its top-performing breast cancer articles of 2021.

A patient with cancer writes about trying acupuncture as another potential tool to lessen the effects of chemo-induced peripheral neuropathy and offers advice for other patients on how to possibly deal with the debilitating side effect.

The FDA’s recent greenlight of a new Keytruda indication gives a large group of patients with melanoma access to a treatment option that they didn’t previously have, says an expert from the UPMC Hillman Cancer Center.

CURE® took a look back at our most-read liver cancer stories from this year.

Take a look back at some of the major milestones in kidney cancer that were achieved in 2021.

“I had to choose one of two paths, to become the victim and let the disease control me or take control of the disease and fight for my life. The moment I chose to fight was the moment life opened all of its beauty,” writes a lymphoma survivor.

A woman with metastatic breast cancer writes a poem about the dark reality of the disease that hides below the surface.

A certified oncology nurse and board-certified adult nurse practitioner explained how the recent FDA approval of Darzalex Faspro, Kyprolis and dexamethasone may allow patients with relapsed/refractory multiple myeloma to switch treatments after discovering their current treatment is no longer working.

An end-of-life conversation may increase hope in patients with cancer, however many patients may be getting it from oncologists when it’s a “too little too late,” an expert said.

The combination of Calquence and Rituxan may also be useful during the COVID-19 pandemic as it decreases infusion times and patient interactions, according to an expert.

Findings from a clinical trial showed that adding Keytruda to neoadjuvant chemotherapy in patients with triple-negative breast cancer significantly improved outcomes and was overall safe and tolerable for patients.

A cancer survivor explains how she feels like she’s living inside a nightmare with new COVID-19 variants appearing all the time, making her unable to see her family over the holidays.

When storytelling becomes a part of one’s identity, it can benefit a wide group of people — such as the MPN community — to share a potentially lifesaving message, according to LeVar Burton.

As treatments for NSCLC improve survival, this benefit may be affected by depression and anxiety, which is common in patients with the disease and may require patients to advocate for cognitive behavioral therapy among other approaches.

An oncology social worker, who is also a cancer survivor, describes life lessons learned through work and personal experiences.

A man writes about his wife’s oncologist, Dr. Frederic J. Kaye, and describes how he went above and beyond to provide supportive care during her lung cancer journey.

There are many cancer clinical trials that patients can enroll in across the United States. Here is a snapshot of some of the more recent ones.

A colleague describes Dr. Nagla Abdel Karim’s exemplary compassion for patients with lung cancer and how she works hard to increase representation in cancer clinical trials.

One male breast cancer survivor explains why he considers his cancer experience an “adventure into the unknown,” where he draws inspiration from every survivor he meets.

A non-Hodgkin’s lymphoma survivor writes about how she chose to approach a stressful doctor’s appointment and how doing whatever helps may look different for everyone.

From the story of HGTV’s “Love it or List it” co-host Hilary Farr’s cancer journey to “Pistol Annies” singer Ashley Monroe ringing the bell after finishing cancer treatment, here’s what’s happening in the cancer landscape this week.

CURE® took a look back at our most-read lung cancer stories from this year.

City of Hope has opened its first-in-human clinical trial for an investigational therapy in patients with advanced breast cancer.

The drug Venclexta may address an unmet need for patients with Waldenström macroglobulinemia via a non-chemotherapeutic, safe and effective treatment option.

The vaccine, which protects patients from seven different strains related to HPV-related cancers, may be considered part of routine oncology care for survivors.